APDN.OB---Sector: Services---Industry: Business Services

[setravis]

Profile: 

 
Applied DNA Sciences Inc.
25 Health Sciences Drive
Suite 113
Stony Brook, NY 11790
United States - Map
Phone: 631-444-6370
Fax: 631-444-8848
Web Site: http://www.adnas.com

DETAILS   
Index Membership: N/A
Sector: Services
Industry: Business Services
Full Time Employees: 12


BUSINESS SUMMARY   
Applied DNA Sciences, Inc. principally develops DNA embedded biotechnology security solutions in the United States and Europe. The company's SigNature DNA solution provides a means to incorporate its SigNature DNA Markers in, and then authenticate and identify a range of items, such as branded products, artwork and collectibles, cash-in-transit, fine wine, digital media, financial instruments, identity cards, and other official documents. Its BioMaterial GenoTyping solution offers a means for determining the authenticity of biomaterials, such as cotton, wool, tobacco, fermented beverages, natural drugs, and foods. The company also manufactures BioActive Ingredients that are used in personal care products, such as skin care products, and in textiles, such as intimate apparel. Applied DNA Sciences, formerly known as Datalink Systems, Inc., was founded in 1983 and is headquartered in Stony Brook, New York.

[setravis]

I like the looks of this chart....Technology % Gainers.
Watch for a pullback..might want to get my toes wet in this one.
Nice surge in the volume...

52wk Range: 0.03 - 0.22
Volume: 7,253,271
Avg Vol (3m): 81,498.4

Technicals
Record Price High
Most Actives
Record Price Break Out...
Percentage Gainer

Last Price Quote is:
inf%above 13-day MA
inf%above 50-day MA
RS Rating: N/A 

Fundamentals
Key Data:
Market Cap (M): $22.31 
P/E Ratio: N/A 
PEG Ratio: N/A 
Next Earnings: N/A
Last Analyst Rating: N/A

[setravis]

Press Release Source: Applied DNA Sciences
Applied DNA Sciences Opens Authentication Laboratory in Yorkshire, UK
Immediately Begins Testing Bank Notes Recovered by UK Police
Thursday April 16, 2009, 8:30 am EDT


STONY BROOK, NY--(MARKET WIRE)--Apr 16, 2009 -- Applied DNA Sciences, Inc. (OTC BB:APDN.OB - News), a provider of DNA security solutions, announced today that it has opened an authentication laboratory in Huddersfield, Yorkshire, UK. This laboratory will produce forensic evidence of originality and product identity, and will be operated by APDN's subsidiary, Applied DNA Sciences Europe Ltd. Located at the Textile Centre of Excellence, this new facility will be utilized to service all of APDN's business, including the immediate goals of expanding both the SigNature® DNA and BioMaterial GenoTyping® Textile programs, and providing authentication services for the Cash-In-Transit industry.

Tony Benson, Risk Director for Loomis UK, stated, "DNA stands strongly on its own merit as the ultimate reality check. Loomis uses SigNature DNA in its cash boxes to ensure that when cash is stolen it is stained with the DNA and that criminals who come into contact with the cash are also stained with the DNA. This is a significant deterrent to criminals, as they stand a far greater chance of being convicted if they attempt a robbery against Loomis."

Loomis chose to use SigNature DNA because it offers far superior qualities in comparison to other taggants. Loomis won an award for its use of SigNature DNA from the International Association of Currency Affairs at their recent conference in Prague for "Best New Product, Process or Currency System."

DNA is a form of forensic evidence trusted by police and recognized by international courts around the world. Once it is applied onto any surface, DNA resists removal. SigNature DNA is distinct from every other taggant in the market because every mark is unique, cannot be copied, or re-engineered. SigNature DNA withstands testing at physicochemical extremes and can be authenticated in a diverse range of substrates.

"SigNature DNA provides Loomis' customers and employees with the 'peace of mind' they deserve and assists the UK Police in detecting crime and convicting criminals," commented Tony Benson.

SigNature DNA is combined with "degradation" dyes that leave a visible stain on currency which is the hallmark used by banks to remove the note from circulation. Included in the DNA-dye complex are invisible dyes used by the UK Police to verify DNA-marked notes. SigNature DNA is sprayed onto currency in ATMs or Cash Transport boxes whenever they are disturbed.

Expansion into the UK will help APDN better serve its growing international market throughout Europe and support a number of new corporate objectives. APDN will begin immediately testing recovered bank notes to assist UK Police in prosecuting apprehended suspects to the fullest extent of the law.

Bill Macbeth, Managing Director, Textile Centre of Excellence, commented, "We are very pleased to welcome Applied DNA Sciences to this facility, and I congratulate the team on successfully growing their business and reputation in DNA Authentication here in Yorkshire."

Fiona Macleod, the UK Vice Consul Trade and Investment stated, "We are impressed with the technology that Applied DNA Sciences provides to help the UK economy, from Cash-In-Transit, right through to ensuring Made-In-Britain products are genuine. UK Trade and Investment, together with Yorkshire Forward, welcome Applied DNA Sciences to the UK and look forward to assisting them with future developments."

About Loomis

Loomis offers products and services that provide complete cash logistics solutions for financial institutions, retailers and other commercial enterprises. Loomis is present in twelve European countries and in the USA and has just over 20,000 employees. Loomis, is a world leading Cash Handling Organisation and in the UK handles over £150 billion in cash annually. To learn more, go to www.loomis.com. Loomis is listed on the NASDAQ OMX Stockholm exchange's MidCap list.

About APDN

APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied. APDN also provides BioMaterial GenoTyping(TM) by detecting genomic DNA in natural materials to authenticate finished products. Both technologies protect brands and products in a wide range of industries and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to www.adnas.com.

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 16, 2008 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.

Contact:
          INVESTOR CONTACT:
     Debbie Bailey
     631-444-8090
     fax: 631-444-8848
     
     MEDIA CONTACT:
     Janice Meraglia
     631-444-6293
     fax: 631-444-8848
     
     FCMN Contact: Email Contact
     Web site: http://www.adnas.com

[njjack495]

Applied DNA Attracting Banks, Insurance and Government Customers
Demonstrable ROI Is Securing New Customers and Validating Business Model


Share
retweet
EmailPrint..Companies:APPLIED DNA SCIENCES.Related Quotes
Symbol Price Change
APDN.PK 0.06 0.00


{"s" : "apdn.pk","k" : "a00,a50,b00,b60,c10,g00,h00,l10,p20,t10,v00","o" : "","j" : ""} Press Release Source: Applied DNA Sciences, Inc. On Monday March 14, 2011, 8:00 am
STONY BROOK, NY--(Marketwire - 03/14/11) - Applied DNA Sciences, Inc. (Pinksheets:APDN - News) announces new customers and inquiries within the governments and the banking and insurance industries.

Applied DNA provides DNA markers to protect cash and valuables in transit (CViT), to protect brand owners, and to secure legitimate supply chains against the diversion to gray markets and against the infiltration of counterfeit products. The company's approach to each vertical market has been to sell its unique, uncopyable DNA tags to suppliers whose components enter at the bottom or through multiple points within a supply chain, and then license the platform to "pain points" that experience the most liability.

Licensing Model Similar to Software Industry
For example, within the cash transportation industry, APDN sells its DNA markers to the security ink users, ATM cassette manufacturers, and cash box manufacturers, who supply their DNA-enhanced products to security companies and ATM owners. However, the security value in the event of theft can only be realized if the risk-owner has licensed the platform from APDN.

License Unlocks the DNA Sequence Key
"Our model is similar to that employed by the software industry," said Dr. James Hayward, CEO of APDN. "We ensure widespread deployment of our DNA marks within an industry, in the same manner as software developers distribute software via laptops and device manufacturers. Our licensees can only realize the value of the DNA markers, just as software must be licensed to enjoy its value." He continued: "Our DNA sequence content is only available to our licensees. We maintain control of our sequences, and only we can authenticate the cash stolen and provide forensic support in an act perpetrated against a risk-owner, which is initially the cash-in-transit transporter, but ultimately includes the financial institution and their insurer."

APDN now has a proven track record within the CViT industry. With over 22 convictions to its credit, APDN has a 100% conviction record for captured criminals who have stolen cash from its security licensees within the UK. The result, the deterrence provided by APDN, yielded a significant drop in attacks and eliminated cash losses more than one hundred times the cost of annual licensing.

Proven Return on Investment
This proven ROI has brought APDN customers higher up the risk chain. "Banks, insurers and governments are now recognizing the deterrence that can only be provided by DNA markers," said Dr. Hayward. "We have received initial orders from governments and insurers, and we are fielding inquiries from banks internationally. The increased demand contributed to the closing of the best quarter in our company's history, announced in SEC filings that describe our first FY11 quarter, ending December 2010."

About APDN
APDN sells patented DNA security solutions that provide anti-counterfeit protection, as well as protecting brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used for product authentication in a unique manner that essentially cannot be copied. When used in conjunction with other law enforcement technologies, SigNature DNA can provide a forensic chain of evidence that has been used successfully in more than 22 convictions. To learn more, go to www.adnas.com where APDN routinely posts all press releases.

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.